XIANYANG, China, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (the “Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement...
Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice PR Newswire XIANYANG, China, April 23, 2018 XIANYANG, China, April 23, 2018 /PRNewswire/ -- Biostar Pharmaceuticals, Inc...
Biostar Pharmaceuticals, Inc. Announces Plans to Launch a New eCommerce Sales Platform PR Newswire XIANYANG, China, Feb. 21, 2018 XIANYANG, China, Feb. 21, 2018 /PRNewswire/ -- Biostar...
Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification PR Newswire XIANYANG, China, Feb. 7, 2018 XIANYANG, China, Feb. 7, 2018 /PRNewswire/ -- Biostar Pharmaceuticals, Inc...
Biostar Regains Compliance with NASDAQ Continued Listing Requirement PR Newswire XIANYANG, China, Dec. 4, 2017 XIANYANG, China, Dec. 4, 2017 /PRNewswire/ -- Biostar Pharmaceuticals, Inc...
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Nine Months Ended September 30, 2017 PR Newswire XIANYANG, China, Nov. 20, 2017 XIANYANG, China, Nov. 20, 2017 /PRNewswire/...
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2017 PR Newswire XIANYANG, China, Nov. 15, 2017 XIANYANG, China, Nov. 15, 2017 /PRNewswire/ - Biostar...
Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice PR Newswire XIANYANG, China, Aug. 28, 2017 XIANYANG, China, Aug. 28, 2017 /PRNewswire/ -- Biostar Pharmaceuticals, Inc...
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2017 PR Newswire XIANYANG, China, May 19, 2017 XIANYANG, China, May 19, 2017 /PRNewswire/ - Biostar...
Biostar Pharmaceuticals, Inc. Announces Its Annual Results for The Year Ended December 31, 2016 PR Newswire XIANYANG, China, April 13, 2017 XIANYANG, China, April 13, 2017 /PRNewswire/ - Biostar...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 3300 | 1.0E-6 | CS |
4 | -9.9E-5 | -99 | 0.0001 | 0.001 | 1.0E-6 | 1938 | 0.00013181 | CS |
12 | 0 | 0 | 1.0E-6 | 0.001 | 1.0E-6 | 1579 | 0.00012944 | CS |
26 | 0 | 0 | 1.0E-6 | 0.001 | 1.0E-6 | 2231 | 0.00011302 | CS |
52 | 0 | 0 | 1.0E-6 | 0.001 | 1.0E-6 | 6999 | 4.094E-5 | CS |
156 | 0 | 0 | 1.0E-6 | 0.01 | 1.0E-6 | 3853 | 0.00011178 | CS |
260 | -0.040099 | -99.9975062344 | 0.0401 | 0.379 | 1.0E-6 | 4536 | 0.10194916 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales